A pilot study to evaluate the safety and efficacy of multiple BLI801 doses in constipated adults.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
81
BLI801 laxative - oral solution
BLI801 laxative - oral solution
Anaheim Clinical Trials
Anaheim, California, United States
Commonwealth Clinical Studies
Brockton, Massachusetts, United States
Clinsearch
Chattanooga, Tennessee, United States
Memphis Gastroenterology
Germantown, Tennessee, United States
Treatment Success
percent of patients experiencing a response in 3 out of 4 weeks of treatment
Time frame: 4 weeks
serum chemistry
Time frame: 4 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.